Skip to main content
Torrent Pharmaceuticals Ltd. logo

Torrent Pharmaceuticals Ltd. — Investor Relations & Filings

Ticker · TORNTPHARM ISIN · INE685A01028 LEI · 335800NA6HK275RIJE13 BSE.NS Manufacturing
Open in API
Filings indexed 1,765 across all filing types
Latest filing 2021-09-24 Share Issue/Capital Cha…
Country IN India
Listing BSE.NS TORNTPHARM

About Torrent Pharmaceuticals Ltd.

https://www.torrentpharma.com

Torrent Pharmaceuticals Ltd. is a research-driven organization focused on the development, manufacturing, and marketing of generic formulations. The company holds a significant position in therapeutic areas such as cardiovascular, central nervous system, gastrointestinal, diabetology, and anti-infective treatments. It has strategically expanded its portfolio into dermatology, nephrology, and pain management through targeted acquisitions. The firm operates across multiple international markets, supported by advanced research and development centers and manufacturing facilities that adhere to global regulatory standards. Its core operations prioritize chronic therapy leadership and the provision of high-quality healthcare solutions through a robust pipeline of generic and value-added medicines.

Recent filings

Filing Released Lang Actions
Loss of Share Certificates
Share Issue/Capital Change Classification · 95% confidence The document is a formal letter addressed to stock exchanges (BSE and NSE) regarding the issuance of a duplicate share certificate. It references Regulation 39 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to share certificate matters. The content is about a specific share certificate issuance and does not contain financial data, earnings, management discussion, or any report publication. It is an announcement related to share certificates, which falls under share capital changes or share issue notifications. Therefore, the most appropriate classification is Share Issue/Capital Change (SHA). The document length is short and it is not a report or announcement of a report publication, so RPA or RNS is not suitable.
2021-09-24 English
Intimation of Issue of Duplicate Share Certificate
Share Issue/Capital Change Classification · 95% confidence The document is a formal letter addressed to stock exchanges (BSE and NSE) informing them about the issuance of a duplicate share certificate. It references Regulation 39 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to share certificate matters. The content is about a specific corporate action related to share certificates, not about financial results, management changes, or other report types. This fits the category of Share Issue/Capital Change (SHA), as it involves changes in share certificates issued to shareholders. The document length is short and it is not an announcement of a report publication, nor a certification or regulatory filing. Therefore, the best classification is SHA with high confidence.
2021-09-24 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice dated 24th September 2021 from Torrent Pharmaceuticals Limited addressed to stock exchanges (BSE and NSE). It informs about the schedule of an upcoming investor meeting (Investor Meet) on 28th September 2021. The document references compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The content is an announcement of a scheduled investor event rather than a detailed report or presentation. The document length is only 1418 characters, indicating it is a brief announcement rather than a full investor presentation or report. Therefore, the most appropriate classification is Regulatory Filings (RNS), as it is a general regulatory announcement about an investor meeting schedule and does not contain financial data or detailed presentation material.
2021-09-24 English
Intimation of Schedule of Investor Meet under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings Classification · 95% confidence The document is a short notice (1418 characters) addressed to stock exchanges (BSE and NSE) regarding the schedule of an investor meeting. It references compliance with SEBI Listing Obligations and Disclosure Requirements Regulation 30, which pertains to disclosure of material events. The content is an announcement of an upcoming investor meeting, not a detailed report or transcript. It does not contain financial data, management discussion, or detailed presentation materials. Given the short length and nature of the content, it is an announcement of an event rather than the event material itself. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2021-09-24 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice addressed to stock exchanges about the schedule of an upcoming investor meeting. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The content is an announcement of an investor meeting schedule, not a report or transcript of the meeting itself. The document length is only 1494 characters, indicating it is a brief announcement rather than a detailed report or transcript. Therefore, it fits best under the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other specific categories.
2021-09-18 English
Intimation of Schedule of Investor Meet under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings Classification · 95% confidence The document is a short notice informing stock exchanges about the schedule of an upcoming investor meeting, specifically a virtual investor conference. It references compliance with SEBI Listing Obligations and Disclosure Requirements Regulation 30, which pertains to disclosure of material events. The document does not contain any financial data, detailed report, or results. It is an announcement of an event (investor meeting) rather than a report or transcript. The length is only 1494 characters, indicating it is a brief notice. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2021-09-18 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.